| Budget Amount *help |
¥196,560,000 (Direct Cost: ¥151,200,000、Indirect Cost: ¥45,360,000)
Fiscal Year 2021: ¥33,150,000 (Direct Cost: ¥25,500,000、Indirect Cost: ¥7,650,000)
Fiscal Year 2020: ¥33,150,000 (Direct Cost: ¥25,500,000、Indirect Cost: ¥7,650,000)
Fiscal Year 2019: ¥33,150,000 (Direct Cost: ¥25,500,000、Indirect Cost: ¥7,650,000)
Fiscal Year 2018: ¥33,150,000 (Direct Cost: ¥25,500,000、Indirect Cost: ¥7,650,000)
Fiscal Year 2017: ¥63,960,000 (Direct Cost: ¥49,200,000、Indirect Cost: ¥14,760,000)
|
|---|
| Outline of Final Research Achievements |
The Center for the analysis of Cellular Society of Inflammation, which supports scRNA-seq, various omics analyses, and information analysis, was set up under the General Affairs Group to support each planned and publicly research project. By using the standardized and optimized cell preparation technology of the project leaders and the highly sensitive and accurate scRNA-seq technology developed originally by the project leaders as the common basic technology for the project, a disease scRNA-seq database was constructed to enable cross-sectional data comparison across diseases and organs. We have also established a novel information analysis technology for biological interpretation of these data. Various target cells and molecules that could lead to the prevention and treatment of individual diseases have been obtained, and are expected to be applied to clinical development and disease prevention and treatment in the future.
|
